{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T06:07:53Z","timestamp":1789366073843,"version":"build-2803163510"},"reference-count":33,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2006,4,1]]},"DOI":"10.1097\/01.qai.0000218344.88304.db","type":"journal-article","created":{"date-parts":[[2006,5,1]],"date-time":"2006-05-01T08:05:17Z","timestamp":1146470717000},"page":"453-460","source":"Crossref","is-referenced-by-count":66,"title":["Dyslipidemia Among Perinatally HIV-Infected Children Enrolled in the PACTS-HOPE Cohort, 1999-2004"],"prefix":"10.1097","volume":"41","author":[{"given":"Rosalind J.","family":"Carter","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey","family":"Wiener","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elaine J.","family":"Abrams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Farley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Nesheim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Palumbo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Bulterys","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-8-20210131","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1056\/NEJMoa011157","article-title":"The impact of protease inhibitor combination therapy on mortality among children and youth infected with HIV-1.","volume":"345","author":"Gortmaker","year":"2002","journal-title":"N Engl J Med"},{"key":"R2-8-20210131","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1097\/00002030-200306130-00006","article-title":"Serum lipids, glucose homeostasis and abdominal adipose tissue distribution in protease-inhibitor-treated and naive HIV-infected children.","volume":"17","author":"Bitnun","year":"2003","journal-title":"AIDS"},{"key":"R3-8-20210131","doi-asserted-by":"crossref","first-page":"e56","DOI":"10.1542\/peds.110.5.e56","article-title":"Marked dyslipidemia in human immunodeficiency virus-infected children on protease inhibitor-containing antiretroviral therapy.","volume":"110","author":"Lainka","year":"2002","journal-title":"Pediatrics"},{"key":"R4-8-20210131","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1089\/088922201316912727","article-title":"Metabolic abnormalities in HIV type1-infected children treated and not treated with protease inhibitors.","volume":"17","author":"Melvin","year":"2001","journal-title":"AIDS Res Hum Retrovir"},{"key":"R5-8-20210131","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1097\/01.aids.0000131334.38172.01","article-title":"Antiretroviral therapy, fat redistribution and hyperlipidemia in HIV-infected children in Europe.","volume":"18","year":"2004","journal-title":"AIDS"},{"key":"R6-8-20210131","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1097\/00126334-200304150-00003","article-title":"Increased lipodystrophy is associated with increased exposure to highly active antiretroviral therapy in HIV-infected children.","volume":"32","author":"Vigano","year":"2003","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R7-8-20210131","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1097\/00002030-200009290-00008","article-title":"Clinical and metabolic presentation of the lipodystrophic syndrome in HIV-infected children.","volume":"14","author":"Jaquet","year":"2000","journal-title":"AIDS"},{"key":"R8-8-20210131","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1097\/00006454-200205000-00011","article-title":"Lipodystrophy syndrome in human immunodeficiency virus-infected children.","volume":"21","author":"Amaya","year":"2002","journal-title":"Pediatr Infect Dis J"},{"key":"R9-8-20210131","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1097\/00126334-200105010-00005","article-title":"Lipodystrophy in HIV-infected children is associated with high viral load and low CD4 lymphocyte count and CD4 lymphocyte percentage at baseline and use of protease inhibitors and stavudine.","volume":"27","author":"Arpadi","year":"2001","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R10-8-20210131","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1097\/01.qai.0000139397.30612.96","article-title":"Prevalence of elevated cholesterol and associated risk factors among perinatally HIV-infected children (4-19years) in PACTG 219C.","volume":"38","author":"Farley","year":"2005","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R11-8-20210131","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1001\/jama.290.17.2271","article-title":"Childhood cardiovascular risk factors and carotid vascular changes in adulthood.","volume":"290","author":"Li","year":"2003","journal-title":"JAMA"},{"key":"R12-8-20210131","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1001\/jama.290.17.2277","article-title":"Cardiovascular risk factors in childhood and carotid artery intima-media thickness in adulthood.","volume":"290","author":"Raitakari","year":"2003","journal-title":"JAMA"},{"key":"R13-8-20210131","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1016\/S0140-6736(02)11672-2","article-title":"Protease inhibitors and cardiovascular outcomes in patients with HIV-1.","volume":"360","author":"Holmberg","year":"2002","journal-title":"Lancet"},{"key":"R14-8-20210131","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1056\/NEJMoa030218","article-title":"Combination antiretroviral therapy and the risk of myocardial infarction.","volume":"349","author":"Friis-Moller","year":"2003","journal-title":"N Engl J Med"},{"key":"R16-8-20210131","doi-asserted-by":"crossref","first-page":"2479","DOI":"10.1097\/00002030-200311210-00010","article-title":"Increased risk of myocardial infarction with duration of protease inhibitor therapy in HIV-infected men.","volume":"17","author":"Mary-Krause","year":"2003","journal-title":"AIDS"},{"key":"R17-8-20210131","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1097\/00126334-200207010-00004","article-title":"Hyperlipidemia in HIV-infected children treated with protease inhibitors: relevance for cardiovascular diseases.","volume":"30","author":"Cheseaux","year":"2002","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R18-8-20210131","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1097\/00002030-200001070-00006","article-title":"Effect of ritonavir on lipids and post-heparin lipase activities in normal subjects.","volume":"14","author":"Purnell","year":"2000","journal-title":"AIDS"},{"key":"R19-8-20210131","doi-asserted-by":"crossref","first-page":"e275","DOI":"10.1542\/peds.111.3.e275","article-title":"Impact of protease inhibitor substitution with efavirenz in HIV-infected children: results of the first pediatric switch study.","volume":"111","author":"McComsey","year":"2003","journal-title":"Pediatrics"},{"key":"R20-8-20210131","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1111\/j.1749-6632.2000.tb05491.x","article-title":"Lack of evidence of mitochondrial dysfunction in the offspring of HIV infected women: retrospective review of perinatal exposure to antiretroviral drugs in the Perinatal AIDS Collaborative Transmission Study.","volume":"918","author":"Bulterys","year":"2000","journal-title":"Ann N Y Acad Sci"},{"key":"R21-8-20210131","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1097\/00002030-200304110-00012","article-title":"Maternal heath factors and early pediatric antiretroviral therapy influence the rate of perinatal HIV-1 disease progression in children.","volume":"17","author":"Abrams","year":"2003","journal-title":"AIDS"},{"issue":"S","key":"R23-8-20210131","first-page":"525","article-title":"Report of the expert panel on blood cholesterol levels in children and adolescents.","volume":"89","author":"Lauer","year":"1992","journal-title":"Pediatrics"},{"issue":"RR-12","key":"R24-8-20210131","first-page":"1","article-title":"1994 revised classification system for human immunodeficiency virus infection in children less than 13 years of age.","volume":"43","year":"1994","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"R25-8-20210131","doi-asserted-by":"crossref","first-page":"121","DOI":"10.2307\/2531248","article-title":"Longitudinal data analysis for discrete and continuous outcomes.","volume":"42","author":"Zeger","year":"1986","journal-title":"Biometrics"},{"key":"R27-8-20210131","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1258\/0956462011923507","article-title":"Dyslipidaemia in HIV-infected patients: association with adherence to potent antiretroviral therapy.","volume":"12","author":"Vergis","year":"2001","journal-title":"Int J STD AIDS"},{"key":"R28-8-20210131","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1097\/00126334-200306010-00016","article-title":"Assessment of adherence to antiviral therapy in HIV-infected children using the Medication Event Monitoring System, pharmacy refill, provider assessment, caregiver self-report, and appointment keeping.","volume":"33","author":"Farley","year":"2003","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R29-8-20210131","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1097\/01.qai.0000178930.93033.f2","article-title":"Longitudinal evaluation and risk factors of lipodystrophy and associated metabolic changes in HIV-infected children.","volume":"40","author":"Beregszaszi","year":"2005","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R30-8-20210131","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1097\/01.inf.0000143646.15240.ac","article-title":"The role of psychosocial and family factors in adherence to antiretroviral treatment in human immunodeficiency virus-infected children.","volume":"23","author":"Mellins","year":"2004","journal-title":"Pediatr Infect Dis J"},{"key":"R31-8-20210131","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1086\/381783","article-title":"Lipid profiles in HIV-infected patients receiving combination antiretroviral therapy: are different antiretroviral drugs associated with different lipid profiles?","volume":"189","author":"Fontas","year":"2004","journal-title":"J Infect Dis"},{"key":"R32-8-20210131","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1046\/j.1525-1497.2000.03509.x","article-title":"Blood cholesterol screening: influence of fasting state on cholesterol results and management decisions.","volume":"15","author":"Craig","year":"2000","journal-title":"J Gen Intern Med"},{"key":"R34-8-20210131","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1038\/sj.ijo.0801594","article-title":"Parameters of childhood obesity and their relationship to cardiovascular risk factors in healthy prepubescent children.","volume":"25","author":"Geiss","year":"2001","journal-title":"Int J Obes Relat Metab Disord"},{"key":"R35-8-20210131","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1111\/j.1651-2227.1994.tb13177.x","article-title":"Waist measurement correlates to a potentially atherogenic lipoprotein profile in obese 12-14-year-old children.","volume":"83","author":"Flodmark","year":"1994","journal-title":"Acta Paediatr"},{"key":"R36-8-20210131","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1080\/078538902317338652","article-title":"Evaluation of cardiovascular risk factors in HIV-1 infected patients using carotid intima-media thickness measurement.","volume":"34","author":"Mercie","year":"2002","journal-title":"Ann Int Med"},{"key":"R37-8-20210131","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/S0021-9150(01)00736-5","article-title":"Assessment of atherosclerosis using carotid ultrasonography in a cohort of HIV-positive patients treated with protease inhibitors.","volume":"162","author":"Seminari","year":"2002","journal-title":"Atherosclerosis"}],"container-title":["JAIDS Journal of Acquired Immune Deficiency Syndromes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00126334-200604010-00008","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T15:21:31Z","timestamp":1785856891000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00126334-200604010-00008"}},"subtitle":["A Longitudinal Analysis"],"short-title":[],"issued":{"date-parts":[[2006,4,1]]},"references-count":33,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2006]]}},"URL":"https:\/\/doi.org\/10.1097\/01.qai.0000218344.88304.db","relation":{},"ISSN":["1525-4135"],"issn-type":[{"value":"1525-4135","type":"print"}],"subject":[],"published":{"date-parts":[[2006,4,1]]}}}